CJC-1295 + Ipamorelin is a research peptide blend that combines two complementary growth hormone secretagogues to support investigations into natural growth hormone regulation, endocrine function, and metabolic health. This synergistic combination is widely studied for its ability to enhance physiological growth hormone release through two distinct yet complementary signaling pathways.
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to promote the natural pulsatile release of growth hormone. It is extensively researched for its potential role in supporting cellular regeneration, protein synthesis, tissue repair, and metabolic regulation. Ipamorelin, a highly selective growth hormone secretagogue (GHS), activates the ghrelin receptor (GHS-R1a) to further stimulate endogenous growth hormone secretion while maintaining a highly targeted mechanism of action.
When combined, CJC-1295 and Ipamorelin are commonly investigated for their synergistic effects on growth hormone signaling, muscle recovery, lean muscle development, body composition, tissue regeneration, and overall metabolic performance. This peptide blend has become a popular subject of research in regenerative medicine, exercise physiology, healthy aging, and endocrine science due to its ability to support sustained and physiologically balanced growth hormone release.
Reviews
There are no reviews yet.